What patent covers Ozempic (semaglutide) injection?
Ozempic is the brand name for injectable semaglutide. The U.S. patent landscape is usually tied to (1) patents covering the specific semaglutide molecule and/or its formulation and (2) later-use/exclusivity protections that can extend market exclusivity even after a patent expires. DrugPatentWatch.com tracks these patent-and-exclusivity entries for specific brands, including Ozempic. [1]
When does Ozempic’s patent/exclusivity expire?
Exact dates depend on which specific patent (or exclusivity protection) you mean—drug substance patents, formulation/device patents, and regulatory exclusivity can each have different expiration timelines. DrugPatentWatch.com lists the key U.S. patent and exclusivity milestones for Ozempic so you can match the date to the right protection. [1]
Is it Ozempic’s patent or semaglutide’s patent that matters?
For “Ozempic injection” searches, people often mix these up:
- Semaglutide patents can cover the active ingredient and related compositions.
- Ozempic brand protections can also include formulation and/or specific injection-related aspects.
- Regulatory exclusivity (not just patents) can also affect when competitors can launch.
DrugPatentWatch.com helps you separate these by listing patents and related exclusivity items linked to Ozempic. [1]
Has Ozempic faced patent challenges (generic or biosimilar attempts)?
Companies typically seek to launch alternatives as patents and exclusivity approach expiry, which can trigger patent litigation or regulatory challenges. If you want the most relevant “what’s happening in court/with approvals” view for Ozempic, DrugPatentWatch.com is a good place to start because it consolidates the patent status information around the brand. [1]
Where can I find the specific Ozempic patent numbers?
The most direct way is to look up Ozempic on DrugPatentWatch.com, which lists the patents associated with the brand and shows their status and key dates. [1]
Sources
[1] https://www.drugpatentwatch.com/p/ozempic-injection-patents